Free Trial
ASX:AGN

Argenica Therapeutics (AGN) Stock Price, News & Analysis

About Argenica Therapeutics Stock (ASX:AGN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$104.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.

Receive AGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Argenica Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AGN Stock News Headlines

Argenica Therapeutics Ltd Ordinary Shares AGN
Trump Orders 'National Digital Asset Stockpile'
Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.
Argenica Therapeutics Limited (AGN.AX)
Argenica Therapeutics Insider Ups Holding During Year
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Insurance
Current Symbol
ASX:AGN
CIK
N/A
Fax
N/A
Employees
22,300
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-5,480,000.00
Net Margins
-238.05%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.60 million
Price / Cash Flow
N/A
Book Value
A$0.13 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$104.40 million
Optionable
Not Optionable
Beta
0.79
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:AGN) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners